Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in INMB — Inmune Bio, Inc.

CIK 1595888 NEW YORK, NY
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$218,797
+$161,231 QoQ
Shares Held
134,232
+163.5% QoQ
Ownership
0.484%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 83 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Derivatives in INMB

reported options exposure · as of Mar 31, 2026
CallValue
$15,933
CallShares
14,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. INMB ranks #167 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in INMB

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $218,797 134,232
2026-03-31 $57,566 50,944
2026-03-31 $15,933 14,100
2025-12-31 $35,812 22,957
2025-09-30 $102,618 49,574
2025-03-31 $141,821 18,159
2024-09-30 $79,367 14,725
2024-03-31 $869,147 73,970
2023-12-31 $485,688 43,134
2021-12-31 $174,398 17,098
2021-09-30 $1,159,374 59,700
2021-09-30 $205,852 10,600
2021-03-31 $145,185 12,221